{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T15:05:52Z","timestamp":1787929552003,"version":"build-2784847793"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,10,16]],"date-time":"2018-10-16T00:00:00Z","timestamp":1539648000000},"content-version":"am","delay-in-days":319,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R56AI099476"],"award-info":[{"award-number":["R56AI099476"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","award":["0965843"],"award-info":[{"award-number":["0965843"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004184","name":"Northeastern University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004184","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.ejmech.2017.10.007","type":"journal-article","created":{"date-parts":[[2017,10,11]],"date-time":"2017-10-11T21:01:32Z","timestamp":1507755692000},"page":"446-459","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["Optimization of physicochemical properties for 4-anilinoquinazoline inhibitors of trypanosome proliferation"],"prefix":"10.1016","volume":"141","author":[{"given":"Jennifer L.","family":"Woodring","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly A.","family":"Bachovchin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly G.","family":"Brady","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitchell F.","family":"Gallerstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessey","family":"Erath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Tanghe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan E.","family":"Leed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kojo","family":"Mensa-Wilmot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard J.","family":"Sciotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9943-7197","authenticated-orcid":false,"given":"Michael P.","family":"Pollastri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2017.10.007_bib1","doi-asserted-by":"crossref","first-page":"5992","DOI":"10.1016\/j.bmcl.2013.08.030","article-title":"The thermodynamic basis for the use of lipophilic efficiency (LipE) in enthalpic optimizations","volume":"23","author":"Shultz","year":"2013","journal-title":"Bioorg Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2017.10.007_bib2","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1021\/cn100008c","article-title":"Moving beyond rules: the development of a central nervous system multiparameter optimization (CNS MPO) approach to enable alignment of druglike properties","volume":"1","author":"Wager","year":"2010","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ejmech.2017.10.007_bib3","series-title":"Human African Trypanosomiasis","author":"World Health Organization","year":"2015"},{"key":"10.1016\/j.ejmech.2017.10.007_bib4","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1016\/j.bmcl.2016.03.103","article-title":"Repurposing strategies for tropical disease drug discovery","volume":"26","author":"Klug","year":"2016","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2017.10.007_bib5","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/cbdd.12443","article-title":"Repurposing human PDE4 inhibitors for neglected tropical diseases. Evaluation of analogs of the human PDE4 inhibitor GSK-256066 as inhibitors of PDEB1 of Trypanosoma brucei","volume":"85","author":"Ochiana","year":"2015","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.ejmech.2017.10.007_bib6","doi-asserted-by":"crossref","first-page":"4084","DOI":"10.1016\/j.bmcl.2014.07.063","article-title":"Repurposing human PDE4 inhibitors for neglected tropical diseases: design, synthesis and evaluation of cilomilast analogues as Trypanosoma brucei PDEB1 inhibitors","volume":"24","author":"Amata","year":"2014","journal-title":"Bioorg Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2017.10.007_bib7","doi-asserted-by":"crossref","first-page":"5971","DOI":"10.1016\/j.bmcl.2013.08.057","article-title":"Synthesis and assessment of catechol diether compounds as inhibitors of trypanosomal phosphodiesterase B1 (TbrPDEB1)","volume":"23","author":"Woodring","year":"2013","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2017.10.007_bib8","doi-asserted-by":"crossref","first-page":"8188","DOI":"10.1021\/jm201148s","article-title":"Pharmacological validation of Trypanosoma brucei phosphodiesterases B1 and B2 as druggable targets for African sleeping sickness","volume":"54","author":"Bland","year":"2011","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2017.10.007_bib9","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1016\/j.bmcl.2012.01.119","article-title":"Synthesis and evaluation of human phosphodiesterases (PDE) 5 inhibitor analogs as trypanosomal PDE inhibitors. Part 1. Sildenafil analogs","volume":"22","author":"Wang","year":"2012","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2017.10.007_bib10","doi-asserted-by":"crossref","first-page":"2582","DOI":"10.1016\/j.bmcl.2012.01.118","article-title":"Synthesis and evaluation of human phosphodiesterases (PDE) 5 inhibitor analogs as trypanosomal PDE inhibitors. Part 2. Tadalafil analogs","volume":"22","author":"Ochiana","year":"2012","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2017.10.007_bib11","doi-asserted-by":"crossref","first-page":"e1297","DOI":"10.1371\/journal.pntd.0001297","article-title":"The susceptibility of trypanosomatid pathogens to PI3\/mTOR kinase inhibitors affords a new opportunity for drug repurposing","volume":"5","author":"Diaz-Gonzalez","year":"2011","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.ejmech.2017.10.007_bib12","doi-asserted-by":"crossref","first-page":"3820","DOI":"10.1021\/jm400349k","article-title":"Kinase scaffold repurposing for neglected disease drug discovery: discovery of an efficacious, lapatinib-derived lead compound for trypanosomiasis","volume":"56","author":"Patel","year":"2013","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2017.10.007_bib13","doi-asserted-by":"crossref","first-page":"4834","DOI":"10.1021\/jm500361r","article-title":"Establishment of a structure-activity relationship of 1H-imidazo[4,5-c]quinoline-based kinase inhibitor NVP-BEZ235 as a lead for African sleeping sickness","volume":"57","author":"Seixas","year":"2014","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2017.10.007_bib14","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1039\/C4MD00441H","article-title":"Evaluation of aromatic 6-substituted thienopyrimidines as scaffolds against parasites that cause trypanosomiasis, leishmaniasis, and malaria","volume":"6","author":"Woodring","year":"2015","journal-title":"Medchemcomm"},{"key":"10.1016\/j.ejmech.2017.10.007_bib15","doi-asserted-by":"crossref","first-page":"5522","DOI":"10.1021\/acs.jmedchem.5b00515","article-title":"Protozoan parasite growth inhibitors discovered by cross-screening yields potent scaffolds for lead discovery","volume":"58","author":"Jennifer","year":"2015","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2017.10.007_bib16","doi-asserted-by":"crossref","first-page":"e3253","DOI":"10.1371\/journal.pntd.0003253","article-title":"Identification and characterization of hundreds of potent and selective inhibitors of Trypanosoma brucei growth from a kinase-targeted library screening campaign","volume":"8","author":"Diaz","year":"2014","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.ejmech.2017.10.007_bib17","doi-asserted-by":"crossref","first-page":"e56150","DOI":"10.1371\/journal.pone.0056150","article-title":"Lapatinib-binding protein kinases in the African trypanosome: identification of cellular targets for kinase-directed chemical scaffolds","volume":"8","author":"Katiyar","year":"2013","journal-title":"PloS one"},{"key":"10.1016\/j.ejmech.2017.10.007_bib18","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1128\/AAC.01691-13","article-title":"New chemical scaffolds for human African trypanosomiasis lead discovery from a screen of tyrosine kinase inhibitor drugs","volume":"58","author":"Behera","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2017.10.007_bib19","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/nrd4683","article-title":"Hit and lead criteria in drug discovery for infectious diseases of the developing world","volume":"14","author":"Katsuno","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2017.10.007_bib20","doi-asserted-by":"crossref","first-page":"32083","DOI":"10.1038\/srep32083","article-title":"Discovery of a carbazole-derived lead drug for human African trypanosomiasis","volume":"6","author":"Thomas","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2017.10.007_bib21","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1021\/cn100007x","article-title":"Defining desirable central nervous system drug space through the alignment of molecular properties, in\u00a0vitro ADME, and safety attributes","volume":"1","author":"Wager","year":"2010","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ejmech.2017.10.007_bib22","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.jmgm.2011.04.004","article-title":"In silico prediction of unbound brain-to-plasma concentration ratio using machine learning algorithms","volume":"29","author":"Chen","year":"2011","journal-title":"J.\u00a0Mol. Graph. Model."},{"key":"10.1016\/j.ejmech.2017.10.007_bib23","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1002\/anie.197508011","article-title":"Tertiary phosphane-tetrachloromethane, a versatile reagent for chlorination, dehydration, and P-N linkage","volume":"14","author":"Appel","year":"1975","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.ejmech.2017.10.007_bib24","doi-asserted-by":"crossref","first-page":"7027","DOI":"10.1016\/S0040-4020(01)00659-7","article-title":"Selective palladium-catalyzed aminations of dichloropyridines","volume":"57","author":"Jonckers","year":"2001","journal-title":"Tetrahedron"},{"key":"10.1016\/j.ejmech.2017.10.007_bib25","first-page":"1581","article-title":"The first Pd-catalyzed aminations of 4-chloro-3(2H)-pyridazinones","author":"Kosmrlj","year":"2000","journal-title":"Synlett"},{"key":"10.1016\/j.ejmech.2017.10.007_bib26","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1039\/C4MD00032C","article-title":"Introduction of polar groups on the naphthalene scaffold of molecular tongs inhibiting wild-type and mutated HIV-1 protease dimerization","volume":"5","author":"Fanelli","year":"2014","journal-title":"MedChemComm"},{"key":"10.1016\/j.ejmech.2017.10.007_bib27","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1055\/s-0029-1218683","article-title":"Copper(II)-Catalyzed conversion of aryl\/heteroaryl boronic acids, boronates, and trifluoroborates into the corresponding azides: substrate scope and limitations","volume":"2010","author":"Grimes","year":"2010","journal-title":"Synthesis"},{"key":"10.1016\/j.ejmech.2017.10.007_bib28","series-title":"Recent Advances in Copper-promoted C-heteroatom Bond Cross-coupling Reactions with Boronic Acids and Derivatives","first-page":"205","author":"Chan","year":"2005"},{"key":"10.1016\/j.ejmech.2017.10.007_bib29","first-page":"2815","article-title":"Novel and facile transformation of N,N-disubstituted glycylamides into corresponding cyanamides by using pentavalent iodine reagents in combination with tetraethylammonium bromide","author":"Chaudhari","year":"2007","journal-title":"Synlett"},{"key":"10.1016\/j.ejmech.2017.10.007_bib30","series-title":"Preparation of Thiazolopyridinones as MCH Receptor Antagonists for Treating and Preventing Symptoms Associated with Obesity and Related Diseases","first-page":"154","author":"Amegadzie","year":"2006"},{"key":"10.1016\/j.ejmech.2017.10.007_bib31","doi-asserted-by":"crossref","first-page":"8923","DOI":"10.1021\/ja0749993","article-title":"Ruthenium-catalyzed azide-alkyne cycloaddition: scope and mechanism","volume":"130","author":"Boren","year":"2008","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2017.10.007_bib32","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1021\/jm4014778","article-title":"Quinoline\u2013pyrimidine hybrids: synthesis, antiplasmodial activity, SAR, and mode of action studies","volume":"57","author":"Singh","year":"2014","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2017.10.007_bib33","doi-asserted-by":"crossref","first-page":"4852","DOI":"10.1016\/j.tet.2011.05.010","article-title":"Microwave-assisted thermal decomposition of formamide: a tool for coupling a pyrimidine ring with an aromatic partner","volume":"67","author":"Loidreau","year":"2011","journal-title":"Tetrahedron"},{"key":"10.1016\/j.ejmech.2017.10.007_bib34","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1039\/C4MD00045E","article-title":"Repurposing human Aurora kinase inhibitors as leads for anti-protozoan drug discovery","volume":"5","author":"Patel","year":"2014","journal-title":"MedChemComm"},{"key":"10.1016\/j.ejmech.2017.10.007_bib35","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/nature19339","article-title":"Proteasome inhibition for treatment of leishmaniasis, Chagas disease and sleeping sickness","volume":"537","author":"Khare","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2017.10.007_bib36","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1002\/jhet.5570230541","article-title":"Applications of 1-alkoxycarbonyl- and 1-acyl-v-triazolo[4,5-b]pyridines as acylating reagents","volume":"23","author":"Torrini","year":"1986","journal-title":"J.\u00a0Heterocycl. Chem."},{"key":"10.1016\/j.ejmech.2017.10.007_bib37","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1021\/ci100031x","article-title":"Conformer generation with OMEGA: algorithm and validation using high quality structures from the Protein Databank and Cambridge Structural Database","volume":"50","author":"Hawkins","year":"2010","journal-title":"J.\u00a0Chem. Inf. Model"},{"key":"10.1016\/j.ejmech.2017.10.007_bib38","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1021\/jm0603365","article-title":"Comparison of shape-matching and docking as virtual screening tools","volume":"50","author":"Hawkins","year":"2007","journal-title":"J.\u00a0Med. Chem."}],"updated-by":[{"DOI":"10.1016\/j.ejmech.2018.05.002","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2018,5,25]],"date-time":"2018-05-25T00:00:00Z","timestamp":1527206400000}}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523417307997?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523417307997?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T13:44:16Z","timestamp":1759326256000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523417307997"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":38,"alternative-id":["S0223523417307997"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2017.10.007","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.ejmech.2018.05.002","asserted-by":"object"}]},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Optimization of physicochemical properties for 4-anilinoquinazoline inhibitors of trypanosome proliferation","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2017.10.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}